Your browser doesn't support javascript.
loading
A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer.
Ramalingam, S S; Kotsakis, A; Tarhini, A A; Heron, D E; Smith, R; Friedland, D; Petro, D P; Raez, L E; Brahmer, J R; Greenberger, J S; Dacic, S; Hershberger, P; Landreneau, R J; Luketich, J D; Belani, C P; Argiris, A.
Afiliação
  • Ramalingam SS; Department of Hematology/Oncology, Winship Cancer Institute of Emory University School of Medicine, Atlanta, USA.
  • Kotsakis A; Department of Medical Oncology, University Hospital of Heraklion, Crete, Greece.
  • Tarhini AA; Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Heron DE; Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Smith R; Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Friedland D; Department of Medicine, Division of Medical Oncology, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Petro DP; Department of Medicine, Division of Medical Oncology, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Raez LE; Department of Medical Oncology, Memorial Cancer Institute, Pembroke Pines, USA.
  • Brahmer JR; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, USA.
  • Greenberger JS; Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Dacic S; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Hershberger P; Department of Pharmacology and Chemical Biology, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Landreneau RJ; Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Luketich JD; Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Belani CP; Department of Medicine, Division of Hematology/Oncology, Penn State Hershey Cancer Institute, Hershey, USA.
  • Argiris A; Department of Medicine, Division of Hematology/Oncology, Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, USA. Electronic address: argiris@uthscsa.edu.
Lung Cancer ; 81(3): 416-421, 2013 Sep.
Article em En | MEDLINE | ID: mdl-23849982
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares Idioma: En Ano de publicação: 2013 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares Idioma: En Ano de publicação: 2013 Tipo de documento: Article